# Multi-colorized tint map for distinguishing triple-negative breast cancers from cysts and fibroadenomas based on the tumor margin

**Authors:** Hongjin Xiang, Xiaoyu Chen, Xiao Tan, Xiangmei Chen, Heng Lv, Desheng Sun

PMC · DOI: 10.3389/fonc.2026.1741453 · Frontiers in Oncology · 2026-02-05

## TL;DR

This study explores using colorized ultrasound images to better distinguish aggressive breast cancers from benign lesions that look similar in standard grayscale scans.

## Contribution

The novel use of HSV-based multi-colorization to highlight tumor margins improves diagnostic accuracy for triple-negative breast cancer.

## Key findings

- Multi-colorized tint maps improved sensitivity and specificity for differentiating TNBC from benign lesions.
- TNBC showed a distinctive peripheral 'halo' pattern absent in benign lesions.
- High inter-reader agreement was observed with colorized images.

## Abstract

Triple-negative breast cancer (TNBC) can appear markedly hypoechoic on grayscale ultrasound and may mimic benign entities such as cysts and fibroadenomas, complicating preoperative differentiation. Because the human visual system is more sensitive to multi-color patterns than to subtle grayscale contrast, we investigated whether hue, saturation, and value (HSV)-based multi-colorized tint maps could improve visual discrimination of TNBC from benign, extremely hypoechoic breast lesions.

This single-center retrospective study included 48 histopathologically confirmed, extremely hypoechoic lesions (16 TNBCs, 16 cysts, and 16 fibroadenomas). Grayscale ultrasound images were post-processed into HSV tint maps using two pre-specified color-coding strategies. A single intensity threshold (135) was predefined and then fixed across all cases to enhance reproducibility; its stability was examined in sensitivity analyses around the selected value. Two radiologists independently reviewed grayscale and colorized images in separate, blinded sessions with randomized case order and a washout interval between sessions to reduce recall bias. Diagnostic performance and inter-reader agreement (Cohen’s κ) were assessed.

Multi-colorized tint maps enhanced subtle marginal echogenic transitions. TNBC more frequently exhibited a distinctive peripheral “halo” pattern, whereas this feature was uncommon in cysts and fibroadenomas. For differentiating TNBC from benign lesions, sensitivity/specificity improved from 75%/69% on grayscale to 88%/91% with multi-colorization. Inter-reader agreement for the colorized interpretation was high (κ =0.88).

HSV-based multi-colorized tint maps reveal a visually intuitive marginal “halo” feature that may assist preoperative differentiation of TNBC from benign, extremely hypoechoic lesions and can improve diagnostic performance compared with grayscale ultrasound. Future multicenter studies should validate robustness across ultrasound vendors and prospectively correlate the halo with histopathologic characteristics (e.g., cellularity and stromal response).

## Linked entities

- **Diseases:** triple-negative breast cancer (MONDO:0005494)

## Full-text entities

- **Genes:** CLEC3B (C-type lectin domain family 3 member B) [NCBI Gene 7123] {aka MCDR4, TN, TNA}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}
- **Diseases:** breast lesion (MESH:D061325), benign lesions (MESH:D001932), cyst (MESH:D003560), TNBC (MESH:D064726), breast cancer (MESH:D001943), malignancies (MESH:D009369), edema (MESH:D004487), HL (MESH:C538324), fibroadenoma (MESH:D018226), lesion (MESH:D009059)
- **Chemicals:** trastuzumab (MESH:D000068878)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916380/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12916380/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916380/full.md

---
Source: https://tomesphere.com/paper/PMC12916380